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Abstract
Background: “Use it o r  lose it" is a well k n o w n  saying w h ic h  is a p p l icab le  t o  b o y s  w ith  D u c h e n n e  M uscular  
D y s tro p h y  (DMD). Besides t h e  d i rec t  e ffec ts  o f  t h e  m u sc u la r  d y s tro p h y ,  t h e  increas ing  effort  t o  p e r fo rm  activities, 
t h e  fear  o f  falling a n d  t h e  u se  o f  pe rso n a l  a ids indirectly  im pair  leg a n d  a rm  fu n c t io n s  as a result  o f  d isuse .  Physical 
t ra in ing  co u ld  o p p o s e  th is  s e c o n d a r y  physical d e te r io ra t io n .  T he  No Use is Disuse  (NUD) s tu d y  is t h e  first s tu d y  in 
h u m a n  su b je c ts  w i th  DMD t h a t  will e x a m in e  w h e t h e r  a low -in tensi ty  physical t ra in ing  is beneficial  in t e r m s  o f  
p re se rv a t io n  o f  m u sc le  e n d u r a n c e  a n d  func tional  abilities. T he  s tu d y  cons is ts  o f  t w o  t ra in ing  in te rv en t io n  studies:  
s tu d y  1 “D y n am ic  leg a n d  a rm  t ra in ing  for a m b u l a n t  a n d  recen t ly  w h e e l c h a i r - d e p e n d e n t  b o y s  w ith  DMD and ,  
s tu d y  2 “Func tiona l  tra in ing  w ith  a rm  s u p p o r t  for b oys  w ith  DMD w h o  h a v e  b e e n  c o n f in e d  to  a w h e e lc h a i r  for 
several years".  This p a p e r  d e sc r ib e s  t h e  h y p o t h e s e s  a n d  m e t h o d s  o f  t h e  NUD study.
Methods: Stu d y  1 is an  exp lo ra t ive  r a n d o m iz e d  co n tro l led  trial w i th  m ult ip le  ba se l ine  m e a s u r e m e n t s .  Thirty b oys  
w ith  a D N A -estab l ished  d iag n o s is  o f  DMD will b e  inc lu d ed .  T he  in te rv en t io n  cons is ts  o f  a s ix -m o n th s  physical 
t ra in ing  d u r in g  w h ic h  b oys  train th e i r  legs a n d  a rm s  w ith  act ive  a n d / o r  ass is ted  cycling tra in ing  e q u ip m e n t .  The  
p r im ary  s tu d y  o u t c o m e s  are  m u sc le  e n d u r a n c e  a n d  func tiona l  abilities, a s se ssed  w ith  a Six-Minute Bicycle Test  a n d  
t h e  M o to r  F u n c t io n  M easure .  S tu d y  2 has  a w i th in - g r o u p  r e p e a te d  m e a s u r e m e n t s  d e s ig n  a n d  will inc lude  t e n  boys  
w ith  DMD w h o  h a v e  a lready  b e e n  c o n f in e d  to  a w h e e lc h a i r  for several years.  T he  s ix -m o n th s  physical tra in ing  
p r o g r a m  cons is ts  o f  1) a c o m p u te r -a s s i s te d  t ra in ing  a n d  2) a func tional  t ra in ing  w ith  an  a rm  s u p p o r t .  T he  pr imary  
s tu d y  o u t c o m e  is func tiona l  abilities o f  t h e  u p p e r  extrem ity ,  a s se ssed  w ith  t h e  Action  R esearch  Arm Test. 
Discussion: T h e  NUD s tu d y  will fill p a r t  o f  t h e  g a p  in t h e  c u r re n t  k n o w le d g e  a b o u t  t h e  p oss ib le  e ffec ts  o f  t ra in ing  
in b oys  w ith  DMD a n d  will inc rease  in s igh t  in to  w h a t  t y p e  o f  exerc ise  sh o u ld  b e  r e c o m m e n d e d  to  b o y s  w ith  
DMD. T he  s tu d y  will finish a t  t h e  e n d  o f  201 0  a n d  results a re  e x p e c te d  in 2011.
Trial registration: T he  N e th e r la n d s  National Trial Regis ter1631
Background
Duchenne Muscular Dystrophy (DMD) is an inherited X 
chromosome-linked recessive myopathy which affects 
approximately 1/4200 live-born boys[1]. DMD is charac­
terized by a total, or near-total (<3%), absence of the 
cell membrane protein dystrophin. The absence of dys­
trophin results in a steady degradation of muscle fibers 
that causes progressive loss of muscle strength and
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functional abilities[2,3]. Boys with DMD are usually con­
fined to a wheelchair at the age of ten years[4] and have 
a median life expectancy of thirty years with spinal sur­
gery and assisted ventilation[5]. Although ongoing stu­
dies show promising therapies that target disease cause, 
there is still no curative (pharmaco)therapy available 
and, thus, treatment remains symptomatic. An impor­
tant aim in the management of boys with DMD is to 
preserve functional abilities for as long as possible[6]. 
Delaying the loss of functional abilities is relevant for all 
activities in daily life and may optimize independence in 
boys with DMD.
© 2010 Jansen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons 
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The loss of functional abilities is primarily the result 
of a progressive decrease in muscle strength and muscle 
endurance during the course of the disease[4,7]However, 
increasingly limited physical and social possibilities gra­
dually cause a secondary reduction of physical activity. 
Indeed, the increasing amount of energy a certain activ­
ity costs, the increasing frequency of falling (with the 
need for help to stand up), and the developing fear of 
falling further reduce leg and arm activities, resulting in 
disuse of the musculoskeletal and cardiorespiratory sys- 
tems[8]. The use of an electrical wheelchair limits arm 
functions (like reaching and lifting) even more, since a 
top blade and a central operating joy stick force boys to 
function within the confines of the wheelchair. As the 
increased sedentary lifestyle results in progressive disuse, 
secondary physical deterioration will occur in all boys 
with DMD. Disuse in DMD thus can be defined as the 
discrepancy between a boy's potential capacity and his 
actual performance. To underscore the importance of 
disuse, previous studies have shown that the presence of 
hip, knee and elbow flexion contractures is strongly 
related to the onset of wheelchair dependence[4]. 
Another example is that boys with DMD have a higher 
risk of bone fractures due to osteoporosis caused by 
unloading[9]. Fractures as a result of falling are followed 
by a loss of ambulation in 20-40 percent of the cases 
[10,11]. In these aspects, the well-known saying "use it 
or lose it" is certainly applicable to boys with DMD.
Physical training could oppose the secondary deteriora­
tion of muscle tissue and the loss of functional abilities as 
a result of disuse. However, the number of studies that 
examined the effects of training in DMD is limited, and 
only a few training studies are reported in hum an 
subjects with DMD. These studies focused on resisted 
exercises in ambulatory boys and concluded that sub­
maximal resistance exercises had only limited positive 
effects on muscle strength and timed functional tests 
(such as the time it takes to walk 23 feet) but, im por­
tantly, they did not cause physical deterioration[12-14]. 
Recent studies in mdx mice (an animal model for DMD) 
concluded that voluntary wheel running (dynamic train­
ing) had positive effects on muscle strength[15] and fati­
gue resistance[15-17]. In addition, non-weight bearing 
low-intensity exercises (like swimming) had no detrimen­
tal effects in mdx mice[18]. However, extrapolating data 
from animal studies to humans should only be done with 
great caution because of differences in phenotypic 
expression and biom echanical differences between 
humans subjects and animal models with muscular dys- 
trophy[19]. Based on the currently available evidence, 
and clinical experience, international guidelines recom­
mend ambulatory boys to perform voluntary (eventually 
mechanically-assisted) active exercises (such as swim­
ming) and to avoid eccentric exercises. Non-ambulant
boys are advised to perform  mobilizing passive or 
actively-assisted mobilizing exercises to maintain postural 
symmetry and sitting comfort[20].
The mechanisms by which training may oppose the 
deterioration of muscle tissue is unclear. Muscle fibres 
in DMD are abnormally vulnerable to contraction- 
induced injury due to the absence of mechanical reinfor­
cement of the sarcolemmal membrane[21]. Therefore, 
eccentric exercises should be avoided[22]. On the other 
hand, work-induced damage can enhance muscle regen­
eration and repair[23], and low-stress exercise may pro­
duce beneficial effects on myofiber contractility and 
energetic efficiency[21]. For example, low-intensity 
training decreased oxidative stress m arkers[24] and 
caused a shift from fast-twitch muscle fiber type 2 to 
slow-twitch muscle fiber type 1 in mdx mice[16]. Slow- 
twitch muscle fibers are more resistant to muscle fiber 
degeneration[16,25]. In addition, corticosteroids could 
support the beneficial effect of training in DMD, since 
steroids may prevent post-exercise deterioration of ske­
letal muscle[22].
The currently recommended voluntary exercises to 
maintain comfort and symmetry[6] are widely used in 
daily practice and assume that low-intensity training is 
beneficial and not harmful for boys with DMD. How­
ever, these recommendations are mainly based on the­
ory and there is a need for more research to justify 
these recommendations and to define the optimal exer­
cise programmes[26]. As we expect that a low-intensity 
training may slow-down the secondary decline of muscle 
endurance and functional abilities (figure 1), we devel­
oped the No Use is Disuse (NUD) study protocol to 
answer the clinically relevant questions whether low- 
intensity physical training in boys with DMD is benefi­
cial and does not cause further harm. The NUD study is 
the first to examine the effects of low-intensity physical 
training in human subject with DMD and will fill part 
of the gap in current knowledge about the possible 
effects of training in boys with DMD. The study consists 
of two training intervention studies: study 1 "Dynamic 
leg and arm training for ambulant and recently wheel­
chair-dependent boys with DMD and, study 2 "Func­
tional training with arm support for boys with DMD 
who have been confined to a wheelchair already for sev­
eral years". This paper describes the hypothesis and 
methods of the NUD study.
Methods
Study 1 Dynamic leg and arm training 
Design
Study 1 is an explorative randomized controlled trial 
with multiple baseline measurements. Randomization is 
stratified according to the ambulatory status (ambulant/ 
non-ambulant) of the boys and the boys are allocated to
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Potential effect 
modifiers
Corticosteroids 
Physical activity
Body functions and 
structures
Muscle endurance 
Joint mobility 
Muscle strength 
Intramuscular fibrosis 
Bone density 
Fractures
1
Activities
Functional abilities
Low-intensity physical (Perceived) manual
training —► abilities
Co-interventions Incidence and fear of falls
1
Participation
Health Related Quality of 
-► Life
F igure  1 Hypotheses
the intervention group or the control group in a 2:1 
ratio. The intervention group receives dynamic exercise 
treatment, whereas the control group receives usual care 
(no specific intervention) during 24 weeks. After this 
period, the control group will also receive the physical 
training. Randomization is performed by an independent 
statistician. Despite randomization, differences in base­
line characteristics between the intervention group and 
the control group may still be present due to the rela­
tively small num ber of participants. For this reason,
multiple baseline measurements are performed that will 
allow us to do within-subject analyses as well. Assess­
ments are not blinded, because it was considered vir­
tually impossible to prevent the boys from revealing 
their group allocation to the assessor.
Participants
Thirty ambulatory or recently wheelchair-dependent 
boys with a DNA-established diagnosis of DMD will be 
included (figure 2). There are an estimated four hundred 
boys with DMD in the Netherlands. Inclusion and
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Allocation I------------------ -----------------
Allocated to control group (n=10)
♦ Received allocated intervention (n=9)
♦ Did not receive allocated intervention (n=1)
(reason: cardiomyopathy)
r FOIIOW-UP '
Lost to follow-up (n=1, patient burden)
Discontinued intervention (n=3) (reasons: 
patellar luxation, too young, patient burden)
Lost to follow-up (n=0)
Discontinued intervention (n=1) (reason: 
fatigue)
Figure 2 Progress study 1 Dynam ic leg and arm training. This flowchart is a preliminary version. Final numbers may change depending on 
eligibility as recruitment is not yet complete.
Allocated to intervention (n=19)
♦ Received allocated intervention (n=19)
♦ Did not receive allocated intervention (n=0)
exclusion criteria are described in table 1. Participants 
will be recruited from the Dutch Duchenne Parent Pro­
ject (DPP) database. Members of the DPP will receive 
written information and a registration form. Addition­
ally, we will place an advertisement on the website of 
the Vereniging Spierziekten Nederland (VSN), and reha­
bilitation physicians affiliated with the VSN will be 
asked to make potential participants aware of the NUD 
study. After registration, interested potential participants 
are visited by the primary investigator (MJ) at home for 
providing further information. Parents, and participants 
who are over 12 years of age, need to give w ritten
Table 1 Inclusion and exclusion criteria study 1
Inclusion criteria
A DNA-established diagnosis of DMD
Boys who are at the end of their ambulation phase, and:
-need >5 sec. to get up from the floor or 
-are not able to get up from the floor or 
-are not able to bicycle without assistance
-are dependent on a wheelchair to move over a long distance (>500 m)
informed consent. The study protocol was approved by 
the Medical Ethics Committee Arnhem-Nijmegen, the 
Netherlands.
Intervention: dynamic leg and arm training
Boys train  their legs and arms with bicycle training 
equipment (KPT Cycla, Kinetic, France). As this type of 
training equipment can be used actively or with electri­
cal motor support, it allows a combination of active and 
passive bicycle training. Physical training is additional to 
any regular therapy or daily physical activity that boys 
already take part in, yet all possible co-interventions are 
registered.
Exclusion criteria
Other disabling diseases influencing mobility 
Boys with a clinical symptomatic 
cardiomyopathy
Boys <6 years old
Boys who recently became wheelchair-dependent (approximately 1-2 years after they stopped 
walking), and:
-are able to touch the top of their head with both hands without assistance or 
-are not able to bicycle without assistance 
-are able to use a hand-operated wheelchair
Jansen et al. BMC Pediatrics 2010, 10:55
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Boys train at home or at school (depending on their 
preferences) during 30-min sessions (15 min leg and 15 
min arm training), five days per week during 24 weeks. 
They are instructed to cycle with a continuous speed 
and stimulated to reach 700-1000 revolutions with both 
their legs and arms during each training session without 
getting too tired. Cycling characteristics are standardized 
(figure 3) and crank-arm length is adjusted to the child’s 
height (e.g. a short crank-arm length for small legs and 
arms). Boys are free to choose when they would like to 
train, their training sequence (first arms or legs) and 
whether they want a break between the two 15 min 
training sessions or not. However, these training agree­
ments are decided beforehand and registered in a train­
ing contract to which they should adhere. Additionally, 
the boys are recommended to train while watching tele­
vision to make the training more pleasurable.
Based on general training principles and based on the 
results from previous training studies in boys with DMD 
and in animal models of DMD, the training intensity is 
low to moderate. Intensity is determined by an adjusted 
and modified Six-Minute Bicycle ergometer Test (see 
study outcomes). Boys are encouraged to reach as many 
revolutions as possible during this sub-maximal test. The 
number of revolutions is an indication for training inten­
sity (level of electrical assistance). After six minutes of 
rest, boys cycle for three more minutes at the indicated 
training intensity. During this period, they should be able 
to cycle with a continuous speed of 60 revolutions per 
minute (RPM) with a perceived level of exertion ranging 
from ‘a little tired’ to ‘getting more tired’, as assessed 
with the OMNI Scale of perceived exertion[27]. The pri­
mary investigator will check the training intensity once 
again during a 15 min training session within two weeks 
after the start of the intervention period. This control is
carried out in a home setting, so that training posture 
can be checked as well. When boys are not able to bicycle 
at a continuous speed of approximately 60 RPM without 
having pain or m aintaining the level of ‘getting more 
tired’, the training intensity will be lowered.
As described above, training intensity is based on the 
ability to bicycle at a continuous speed and perceived 
exertion. Intensity is, thus, not based on peak heart rate, 
which is common in the literature on physical exercise 
training. The reason for this is twofold. Firstly, boys 
with DMD have a higher resting heart rate (110 ± 12 
beats/min) compared to healthy controls (94 ± 7 beats/ 
min )[28]. Additionally, boys with DMD are often forced 
to terminate a bicycle ergometry test while their peak 
heart rate is only 120-130 beats/min, since the main 
limiting factor during ergometry seems to be not their 
oxygen transport but their ‘peripheral’ capacity (muscle 
endurance, anaerobic power and muscle strength)[7].
Boys are instructed to send their daily num ber of 
revolutions and their perceived levels of exertion to the 
prim ary investigator by a postal questionnaire once 
every two weeks, together with an overstrain question­
naire. Parents and their boys are informed by telephone 
when compliance is inadequate or when other problems 
(such as signs off overstrain: see adverse events) are 
identified and children are encouraged to resume the 
training or to adjust the training intensity.
Study outcomes
Study outcomes include measurements at the levels of 
body functions and structures, activities and participa­
tion as defined by the International Classification of 
Functioning, Disability and Health (ICF) [29]. Environ­
mental characteristics (school type and home status) are 
assessed at baseline. Demographic variables (age, weight 
and arm span), the use of m edication (such as
Jansen et al. BMC Pediatrics 2010, 10:55
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corticosteroids), any co-interventions and daily amount 
of physical activity are registered during each session.
The assessments of boys in the intervention group are 
conducted during the baseline period (T0: at baseline; 
T1: after 4 weeks; T2: after 8 weeks), the training period 
(T3: after 12 weeks; T4: after 24 weeks) and the follow- 
up (T5: 4 weeks after the end of the training; T6: 24 
weeks after the end of the training). The assessments of 
boys in the control group are conducted during the 
baseline period (T0: at baseline; T1: after 4 weeks; T2: 
after 8 weeks), the control period (T3: after 12 weeks; 
T4: after 24 weeks), the subsequent training period (T5: 
after 12 weeks of training; T6: after 24 weeks of train­
ing) and during the follow-up (T7: 4 weeks after the end 
of the training). Assessments take place at the depart­
ment of Rehabilitation of the Radboud University Nij­
megen Medical Centre (T0, T2, T4, T6), but also at 
home (intervention group: T1, T3, T5; control group: 
T1, T3, T5, T7) to reduce the practical burden on the 
participants. All data are collected by the (trained) pri­
mary investigator (MJ). (figure 4)
Primary outcomes 
Bicycle ergometry: Six-Minute Bicycle Test 
Muscle endurance, in this study defined as ‘the ability 
to sustain a power without the occurrence of peripheral 
fatigue’, is assessed with an adjusted and modified 
bicycle ergometer test for both the lower and upper 
extremities. Bicycle ergometry has been used in many 
studies to examine the (an)aerobic perform ance in 
healthy children and children with disabilities, and sev­
eral exercise protocols are available. However, these pro­
tocols are not feasible for boys with DMD, since large 
muscle groups are affected in DMD and initial load and 
subsequent increments of load are often too hard to 
sustain for these patients[7,30]. Muscle endurance is, 
therefore, examined with a recently developed motor- 
assisted (passive mode 1, no-load speed 7 RPM) Six- 
M inute Bicycle Test by which boys are instructed to 
cycle as fast as possible i.e. to make as many cycling 
revolutions as possible. Boys start with a test for their
legs and, thereafter, perform the same (arm cranking) 
test with their arms.
The occurrence of muscle fatigue during bicycle ergo- 
metry is assessed objectively with bipolar surface elec­
trom yography (sEMG), since peripheral fatigue is 
reflected as an increase in the amplitude and a decrease 
in the median frequency of the sEMG signal[31,32]. 
These param eters were found to be responsive to 
changes in muscle endurance during an exercise pro- 
gram[33,34]. Electrodes are placed unilaterally (right leg, 
right arm) on the m. rectus femoris, m. vastus medialis, 
m. biceps femoris, m. tibialis anterior, m. biceps brachii, 
m. triceps brachii and m. deltoideus. Electrode place­
ment procedures will follow the recommendations for 
Sensor and Sensor Placement Procedures for surface 
electromyography[35]. Data will be registered with an 
EFA system (Twente Medical Systems International). 
The occurrence of muscle fatigue is also assessed sub­
jectively with the OMNI Scale for perceived exertion 
[27]. The OMNI Scale is reliable and valid over a wide 
range of dynamic exercise intensities in children[27,36].
Motor Function Measure
The MFM is a recently developed instrument to assess 
motor function in ambulant and non-ambulant patients 
with neuromuscular diseases (NMD) aged 6-62 years 
[37]. The MFM has shown excellent internal consistency 
and good to excellent intra- and interrater reliability in 
French neuromuscular patients[37]. Vuillerot et al.[38] 
showed that the MFM is able to measure changes in 
m otor function over time in boys with DMD. An 
ongoing study examines validity and applicability of the 
MFM in rehabilitation institutes in the Netherlands. 
Secondary outcomes Table 2 shows an overview of the 
secondary study outcomes and their psychom etric 
properties.
Adverse events
All adverse events will be recorded. The study will be 
term inated prematurely for an individual participant 
when training is excessive and remains excessive after a 
reduction of the training intensity. Signs for overstrain
Figure 4 Measurem ents study 1. BP (Baseline period), IP (Intervention period), FU (Follow-up), CP (Control period)
Jansen et al. BMC Pediatrics 2010, 10:55
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Table 2 Outcome measures and psychometric properties
Level Study outcom e Measurem ent tool Psychom etric properties Assessment
Body 
structures 
and functions
Muscle endurance Six-Minute Bicycle Test* Feasible for ambulant and non-ambulant boys 
with DMD (pilot study, unpublished data)
T0, T2, T5
Joint mobility 
(PROM)
Goniometry[55] (knee ext*, ankle dfl*, 
shoulder abd*", elbow ext*", wrist ext", wrist 
radialand ulnar d ev")
Standardized methods are feasible[56] and 
have good intra- and inter-rater reliability in 
DMD[57]
Passive wrist radialdeviation is correlated with 
functionalhand activities[58] and lower 
extremity contractures are related to onset of 
wheelchair reliance in DMD[4]
All
Muscle strength Modified MRC[59] (hip ext*, knee ext* ankle 
dfl*, shoulder abd*", elbow ext*", wrist ext")
Moderate to good intra-rater reliability[59] and 
acceptable inter-rater reliability in DMD after a 
training session[60]
Muscles with MRC grade 4 or 5 are difficult to 
measure with MMT, but muscles with MRC 
grade <3 are more difficult to measure with 
HHD[4]
All
Muscle atrophy, 
intra-muscular 
fibrosis and fatty 
infiltration
Quantitative skeletalmuscle ultrasonography 
(muscle thickness and echo intensity) [61]: RF, 
TA, BB, FF*"
Good inter-rater agreement in children[62] 
High predictive values to discriminate 
between children with and without a NMD 
[63]
T2, T5, T6/T7*
Bone density Dexascan (femur and lumbar spine)* Changes in bone mineraldensity can be 
detected with confidence in healthy boys >10 
years after 6 months and in younger boys 
after 12 months[64], but a change in body 
shape may influence scan results[65]
Conventional 
protocol for 
each boy
Incidence of 
fractures
Semi-structured interview* All
Activities Functionalabilities Motor Function Measure[37] (D1*, D2*, D3*") Excellent internalconsistency for the global 
scale and the subscales in NMD[37]
Excellent to moderate intra- and inter-rater 
reliability in NMD[37]
Good face validity, convergent validity and 
discriminant validity in NMD[37]
Sufficiently sensitive to detect changes in the 
totalscore in DMD[66]
Totalscore predicts loss of ambulation in 
DMD[67]
All
Upper limb 
function
Action Research Arm Test[40,41] " Excellent intra-rater, inter-rater and test-retest 
reliability in stroke patients[40,41]
Highly correlated with the Fugl-Meyer score47 
and FunctionalIndependence Measure48 in 
stroke patients
Suitable to detect changes over time in stroke 
patients[42]
All
Functionalabilities
(grading)
Vignos* and Brooke Scale*" [56] Good inter-rater and intra-rater reliability[57,57] 
and correlated with timed tests[46,68,69] in 
DMD
All
Functional
mobility
FunctionalMobility Scale[70] * A clinically feasible, valid and reliable toolin  
CP[70,71]
All
Functionalabilities 
(timed tests)
Timed and graded functional tests (and total 
GSGC score) [72]: walk 10 meters, climb 3 
stairs, rise from the floor and rise from a 
chair*
Good to excellent intra- and inter-rater 
reliability in DMD[57,73]
Sensitive to change in DMD: a smallreduction 
in muscle force was accompanied by a large 
increase in time it takes to complete 
functionaltests[74]
All (gait, stairs 
and chair only 
in the 
hospital)
Finger dexterity Nine-hole Peg Test[75] *" Moderately high test-retest reliability, high 
inter-rater agreement and adequate 
concurrent validity in school-age children[76]
All
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Table 2 Outcome measures and psychometric properties (Continued)
Hand function Jebsen-Taylor Hand Function Test[77] ■ Good test-retest reliability in DMD[58] 
Strongly correlated with muscle strength of 
the wrist extensors[58], radial deviation range 
of motion[58] and the Brooke scale[46] in 
DMD
T2, T4, T5
Functionalstatus PEDI[78,79] (selfcare*^ and mobility*) Good inter-rater and test-retest reliability[80], 
content validity[79] and discriminative validity 
[81] in children with various diagnosis 
Feasible for evaluative purposes in CP[81,82]
T0, T2, T4, T6/ 
T7*
Perceived manual 
abilities
Abilhand[83] ■ Abilhand-kids[84] * The Rasch-derived Abilhand is moderately 
related to grip and key pinch strength, has 
good test-retest reliability and may be 
sensitive to change in stroke patients[85]
The Abilhand-kids has good test-retest 
reliability and a higher independence in gross 
motor function is associated with a higher 
manualability in CP[84]
T0, T2, T4, T6/ 
T7*
Quality of upper- 
limb motor 
function
Melbourne Assessment of UnilateralUpper 
Limb Function[86] (item 1,2,3,10,11 and16) 
extended with an upper limb motion analysis 
(Vicon Motion Systems) with 8 cameras■
The Melbourne Assessment has moderate to 
high intra- and inter-rater reliability[87] and 
excellent construct validity in CP[88]
A motion capture analysis system can measure 
task performance with an upper-limb orthosis 
[45], but soft tissue artefacts may negatively 
influence accuracy[49]
T2, T4
Incidence and fear 
of falls
Semi-structured interview* All
Participation HRQoL KIDSCREEN-52[89](child- and parental 
questionnaire)*^
Acceptable levels of reliability and validity in 
children and adolescents[90]
Children's most important in their lives 
generally map well to the items in KIDSCREEN 
[91]
T0, T2, T4, T6/ 
T7*
Dem ographic
variables
Weight and height Body weight (kg)*\ standing height* (cm) 
and arm-span*^ (cm)
T0*, T2, T4, 
Y6/T7*
Co-factors Co-interventions Semi-structured interview*^ All
Physicalactivity Semi-structured interview (according to the 
PAQ-C[92] and the 60-min MVPA measure 
[93])* ■
All
Symbols:* = study 1 'Dynamic leg and arm training', ■ = study 2 'Functional training with arm support'
Abbreviations: DMD: Duchenne Muscular Dystrophy; PROM: Passive Range of Motion; ext: extension; dfl: dorsal flexion; abd: abduction; dev: deviation; MRC: 
Medical Research Council Scale; RF: m. Rectus Femoris; TA: m. Tibialis Anterior; BB: m. Biceps Brachii; FF: forearm flexors; NMD: Neuromuscular Disease; GSGC: 
Gait, Stairs, Gowers, Chair; PEDI: Pediatric Evaluation of Disability Inventory; CP: cerebral palsy; HRQoL: Health-Related Quality of Life; PAQ-C Physical Activity 
Questionnaire for older children; MVPA: Moderate-to-Vigorous Physical Activity
are: excessive muscle pain during the training, p ro ­
longed post-exercise muscle pain, a severely uncomfor­
table feeling during or after the training and extreme 
(muscle) fatigue (OMNI scale > 6).
Sample size
The average ra te of decline (m ean and standard  
deviation (SD)) of muscle endurance and functional 
abilities in boys with DMD, as assessed with bicycle 
ergometry and the M otor Function Measure (MFM), 
is unknown. Therefore, no sample size can be calcu­
lated  for these prim ary outcom es. However, it is 
anticipated that multiple baseline measurements will 
increase the chance of finding statistically significant 
changes in the selected outcome measures. For rea­
sons of convenience, and because this RCT should be 
regarded as a first explorative study, we decided to
include 20 boys in the in terven tion  group and 10 
boys in the control group.
Analysis
A two-way analysis of variance (ANOVA) will be used 
to examine the effects of dynamic leg and arm training 
on the primary outcomes. Secondary outcomes will be 
treated similarly or by non-parametric analyses depen­
dent on the type of outcome (interval or ordinal). Data 
will be analyzed with SPSS version 16.0 and an alpha 
level of 0.05 will be used to decide on statistical 
significance.
Study 2 Functional training with arm support 
Design
Study 2 has an observational one-group design using 
repeated measurements, because we anticipate that it
Jansen et al. BMC Pediatrics 2010, 10:55
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will not be possible to recruit a sufficient number of 
boys for an RCT in the Netherlands. This problem is 
related to the fact that boys with DMD who have been 
confined to a wheelchair already for several years often 
experience many barriers, such as a lack of time due 
to therapy obligations and homework. It is also vir­
tually impossible for them to do without their electric 
w heelchair for a couple of days to build up the 
required arm support for this study. In addition, the 
number of boys at this stage in the course of DMD is 
low (i.e. an estim ated 120 boys in the Netherlands) 
and, it is expected that some of these boys already use 
an arm support, which is an exclusion criteria for 
participation.
Participants
Ten wheelchair-dependent boys with a DNA-established 
diagnosis of DMD will be recruited in the same way as 
the participants of study 1 (figure 5). Inclusion and 
exclusion criteria are described in table 3. Participants 
will receive written information and will be visited by 
the primary investigator at home for providing further 
information. Both parents and participants will need to 
give written informed consent. The study protocol was 
approved by the Medical Ethics Committee Arnhem­
Nijmegen, the Netherlands.
Intervention
The six-months physical training consists of 1) a com­
puter-assisted training and 2) a functional training of 
the non-dominant arm and hand (i.e. the hand one does 
not use for writing) with a mechanical or an electrical 
arm support (Dynamic Arm Support Top/Help, Focal, 
Tilburg, the Netherlands) (figure 6). Boys who are 
unable to touch their nose with a mechanical arm sup­
port (due to insufficient muscle strength) will receive an 
electrical arm support. The arm support transposes 
shoulder movements into movements of the forearm 
and hand, which increases functional abilities and joint 
range of motion in boys with DMD. During the first 
baseline measurement (T0), boys will try to fit the arm 
support under supervision of an experienced representa­
tive of Focal (the m anufacturer of the TOP arm 
support) and the primary investigator. Training of the 
non-dominant arm is additional to any regular therapy. 
All co-interventions will be registered. 
C om puter-assisted tra in ing  Boys play “Furballhunt” 
(developed by Roessingh Research and Development B. 
V. (M.A. Jannink), Enschede, the Netherlands) to prac­
tice targeted forward and sideward reaching movements 
(ipsi- and contra-lateral) as well as lifting movements 
during five days per week. Furballhunt is a computer
F ig u re  5 Progress study 2 Functiona l tra in ing  w ith  arm  support. This flowchart is a preliminary version. Final numbers may change 
depending on eligibility as recruitment is not yet complete.
Jansen et al. BMC Pediatrics 2010, 10:55
http://www.biomedcentral.com/1471-2431/10/55
Page 10 of 15
Table 3 Inclusion and exclusion criteria study 2
Inclusion criteria Exclusion criteria
A DNA-established diagnosis of DMD Other disabling diseases influencing
mobility
Boys who have been wheelchair-dependent for a few years (approximately 2-5 years after they stopped Boys who are able to stand
walking)
Boys >20 years old
Boys who have problems with reaching and lifting movements with their arms, and: Boys who already use an arm support
-are unable to touch the top of their head (at least with one hand)
-are still able to use their hands for some daily activities
game that was originally developed to improve arm 
function in children with cerebral palsy using a virtual 
reality environm ent. Furballhunt is based on motion 
capture technology and uses a webcam (in this study: 
Logitech QuickCam E3500) to detect gross shoulder and 
elbow movements. Birds ("Furballs”) fly from their bird­
house to a tree branch while the boy holds his hand in 
front of his navel. Boys have to touch the Furball when 
it sits down on a tree branch. The faster boys chase 
away Furballs, the higher their score. A virtual reality 
computer game is considered to be a motivational tool 
for training in children[39].
Boys play five games of Furballhunt (30 Furballs per 
game, 30 sec of rest between games) per day at home. 
The number of tree branches (3), game speed (5/10), 
the number of Furballs (30) and the sequence of games 
are standardized. Training intensity is low to moderate,
which means that boys are allowed to perceive their 
exertion as ‘getting a little tired' or ‘getting more tired' 
as assessed with the OMNI Scale[27]. Intensity is 
adjusted to the physical abilities of the boy by varying 
the position of the tree branches, which represent the 
targets to move to. Boys are instructed to move their 
arm over the full range of motion, which may cause a 
feeling of stretch but not pain.
Boys report their training frequency in a diary and 
complete an overstrain questionnaire once every two 
weeks. Parents and their boys are informed by tele­
phone when compliance is inadequate or when other 
problem s (such as signs of overstrain : see adverse 
events) are identified. Boys are encouraged to resume 
the training and to adjust the training intensity, when 
appropriate. The date, training time and reaction times 
are saved on the com puter, so that compliance and 
performance can be checked afterwards by the primary 
investigator.
Functional training  Boys should eat at least one meal 
with the arm  support twice every week. In addition, 
they are instructed “to use the arm support as much as 
possible every day”. Boys keep a written record of all 
activities they perform with the arm support in a three- 
day diary once every two weeks (two weekdays, one 
weekend day).
Study outcomes
Study outcomes include measurements at the levels of 
body functions and structures, activities and participa­
tion of the ICF[29]. Environm ental characteristics 
(school type and home status) are assessed at baseline. 
Demographic variables (age, weight, arm span), the use 
of m edication (such as corticosteroids) and any co­
interventions are registered during each session.
After a two-month period for baseline measurements 
(T0: at baseline; T1: after 4 weeks; T2: after eight weeks) 
to obtain information about the stability of the course of 
DMD, training with the arm support takes place for six 
months. Assessments take place after 12 weeks (T3) and 
24 weeks (T4) training. Finally, one extra measurement 
will be done after 12 more weeks (T5) to evaluate to 
what extent the possible effects of training have lasted. 
Data is collected by the primary investigator (MJ) at the
Jansen et al. BMC Pediatrics 2010, 10:55
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department of Rehabilitation of the Radboud University 
Nijmegen Medical Centre (T2, T4), but also at home 
(T0, T1, T3, T5) to reduce the practical burden on the 
participants. (figure 7).
Primary outcome 
Action Research Arm Test (ARAT)
As no suitable measure of arm m otor function has 
been validated for children with NMD, the functional 
abilities of the upper extremity (reaching, lifting and 
manipulating) are assessed bilaterally with the Action 
Research Arm Test (ARAT)[40]. The ARAT is a stan­
dardized tool for the assessment of arm motor function 
and capacity (both distally and proximally) and consists 
of 19 items in four dimensions: grasp, grip, pinch and 
gross movements. The ARAT has shown to be reliable 
[40,41], valid[40-42] and suitable to detect changes over 
time[42] in stroke patients. The ARAT is performed and 
scored following standardized procedures as described 
by Yazbatiran[41]. The non-dominant arm is assessed 
both with and without arm support.
Secondary outcomes Table 2 shows an overview of the 
secondary study outcomes and their psychometric prop­
erties. Both the dominant and non-dominant arms are 
assessed. The non-dominant arm is assessed both with 
and without arm support.
Adverse events
All adverse events will be recorded. The study will be 
term inated prematurely for an individual participant 
when training is excessive and remains excessive after a 
reduction of the training intensity. Signs for overstrain 
are: excessive muscle pain during the training, p ro ­
longed post-exercise muscle pain, a severely uncomfor­
table feeling during or after the training and extreme 
(muscle) fatigue (OMNI scale > 6).
Sample size
This is a first explorative study that will give an indica­
tion of the effect of functional training with arm support 
on the functional abilities of the upper extremity in boys 
with DMD. In this perspective, no realistic power calcu­
lation can be made. By using a design with multiple 
measurements at baseline we anticipate to find statisti­
cally significant effects of the proposed therapeutic 
intervention in ten boys with DMD.
Analysis
A one-way analysis of variance (ANOVA) of time will be 
used to examine the effects of functional arm training 
with arm support on the primary outcome (ARAT). Sec­
ondary outcomes will be treated similarly or by non- 
parametric analyses dependent on the type of outcome 
(interval or ordinal). Data will be analyzed with SPSS 
version 16.0 and an alpha level of 0.05 will be used to 
decide on statistical significance.
Discussion
This paper presents the research questions, hypotheses 
and methods of the No Use is Disuse (NUD) study in 
the Netherlands. The NUD study examines the effects 
of low-intensity dynamic physical training in boys at dif­
ferent stages in the course of Duchenne Muscular Dys­
trophy (DMD). It is expected that these dynamic 
exercises will be beneficial and will not impose a risk of 
muscle or other injury to the boys. This hypothesis is 
based on the (limited amount of) evidence that is avail­
able about physical training in children with neuromus­
cular diseases (NMD). In addition, the study was 
designed with the extensive input from several experts 
in the field of NMD in children (1 pediatric physiothera­
pist, 2 occupational therapists, 1 rehabilitation physician, 
1 exercise physiologist, 1 neurologist, 1 clinical neuro­
physiologist and 1 epidemiologist). We will discuss the 
most relevant issues and decisions concerning 1) train­
ing (intensity), 2) outcome measures and 3) strategies to 
optimize therapy compliance.
Training (intensity)
Boys in both studies are instructed to train five days per 
week during 24 weeks. Although this training frequency 
is high, it was chosen to elicit as much ‘daily physical 
activity' as possible in every boy. Many boys with DMD, 
especially those who are confined to a wheelchair, have 
a sedentary lifestyle[28] and do not engage in 60 min of 
moderate daily physical activity as recommended by the 
WHO for children to reduce their risk of chronic dis- 
eases[43]. On the other hand, as boys with DMD already 
have a chronic disease, their physical limitations have to 
be taken into account to prevent exercise-induced
Measurement 
Figure  7 Measurem ents study 2. (Baseline period), IP (Intervention period), FU (Follow-up)
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physical deterioration[44]. Nevertheless, the level of 
daily low-intensity physical activity as prescribed in this 
study is thought to be safe and effective in reducing dis­
use atrophy and excessive functional loss.
Although training-induced improvements of muscle 
functions can normally be expected after six weeks of 
physical training[26], we have chosen a training period 
of 24 weeks. This relatively long training period is con­
sidered necessary, as the disease progression is relatively 
slow, and the expected training effects over time prob­
ably small. We also assume that if boys are able to 
adhere to the training regime during these 24 weeks, it 
will be feasible for them to incorporate physical training 
in daily life afterwards.
Boys in study 2 train reaching and lifting movements, 
since reaching is one of the tasks with a high priority in 
potential users of an arm support[45]. Boys train their 
non-dom inant arm as this arm is used less than the 
dominant arm in functional acitivities[46]. Therefore, 
training effects are expected to be larger for the non­
dominant arm. Nevertheless, it may be difficult for boys 
to perform activities (like eating and scratching) with 
their non-dominant arm.
Study outcomes
In this study, reliable functional scales are used, such as 
the MFM, as well as timed tests that have clinically 
meaningful endpoints[47] and that are sufficiently sensi­
tive to detect therapy related gains[48]. Indeed, outcome 
measures should be reliable and sensitive to allow for an 
adequate power in trials with a relatively small sample 
size. As no suitable ergometry test or arm motor function 
test is available for (non-ambulant) boys with NMD, a 
Six-Minute Bicycle test and the ARAT have been selected 
as prim ary outcomes. Pilot studies showed that the 
applied Six-Minute Bicycle test was feasible for both 
ambulant and recently wheelchair-dependent boys with 
DMD. The ARAT proved to be useful in a wheelchair- 
dependent boy with DMD as well (unpublished data). In 
addition, we used an upper extremity protocol to quanti­
tatively measure arm motor function[49] with an eight 
camera motion analysis system (Vicon Motion Systems, 
Ltd, Oxford, UK). It has been shown that such a system 
can accurately measure task performance with an upper- 
limb orthosis[45]. Arm motor function has never been 
measured quantitatively before in boys with DMD, which 
may be of value because of its continuous properties and 
presumably greater sensitivity to change[50].
Strategies to increase therapy compliance
From a previous study, it can be concluded that home- 
based cycling programs for children are feasible and 
show good adherence rates[51]. A home-based program 
allows boys to train at times that are convenient for them
and reduces travel time. However, a home-based pro­
gram requires great discipline from boys and their 
families, and several aspects need attention to optimize 
therapy compliance. One of these aspects, according to 
the Social Cognitive Theory[52], is that the social envir­
onment (e.g. family and school) is essential for a change 
in health behavior. Therefore, to optimize therapy com­
pliance, parents are asked to stimulate their boys by 
reminding them to perform their exercises. In addition, 
siblings can be role models by being physically active 
themselves. O ther strategies that are used to enhance 
behavioral change and optimize therapy compliance are 
specific goal setting[53] and reduction of perceived bar- 
riers[54]. For this reason, as described previously, all boys 
sign a training contract including an agreement on the 
training moments. The barriers that boys or their parents 
might perceive are discussed beforehand. In addition, the 
boys in study 1 are recommended to train while watching 
the television to make the training more pleasurable.
Expected products
The NUD study is the first clinical trial that examines 
the effects of low-intensity physical training on muscle 
endurance and functional abilities in boys with DMD. It 
will be a start to fill the current gap in our knowledge 
about the efficacy of physical training in these boys and 
will increase our insight into what type of physical train­
ing should be recommended. Although the NUD study 
focuses on children with DMD, the results may be 
(partly) applicable to other neuromuscular disorders in 
childhood. Results of the NUD study are expected by 
the end of 2010.
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